Product Information

COTEMPLA XR-ODT 8.6 MG TABLET is a brand product labeled by Neos Therapeutics Brands, LLC, priced at $17.9876 per EA under NDC 70165010030. Its NADAC has been published 432 times since Mar 21, 2018.

The High Outlier badge above means this manufacturer's average price in the Methylphenidate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

COTEMPLA XR-ODT 8.6 MG TABLET

Methylphenidate
$17.9876per EA
High Outlier
DEA Schedule CII

Strength

8.6 mg/1

NDC

70165010030

Classification

Brand

Dosage Form

TABLET, ORALLY DISINTEGRATING

Route

ORAL

Last Updated

4/1/2026

Active Ingredients

METHYLPHENIDATE

Approval Type

New Drug (NDA)

FDA Application

NDA205489

On Market Since

6/20/2017

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price Statistics

The NADAC for COTEMPLA XR-ODT 8.6 MG TABLET has been published 432 times since Mar 21, 2018, and over the history we have for it it has risen 75.0%. The table below summarizes its recorded NADAC range and movement.

Current price$17.9876 per EA
All-time high$17.9876 (Jun 24, 2026)
All-time low$10.2763 (Mar 21, 2018)
52-week high$17.9876
52-week low$17.0661
Median price$14.2903
Average price$14.4092
Largest weekly change+13.2% (Jan 1, 2020)
Weeks tracked432
Tracking sinceMar 21, 2018

Price History

1W

0.0%

1M

0.0%

3M

+5.4%

6M

+5.0%

1Y

+4.9%

3Y

+15.3%

5Y

+26.8%

All

+75.0%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Methylphenidate market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Frequently asked questions

What is the NADAC price of COTEMPLA XR-ODT 8.6 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for COTEMPLA XR-ODT 8.6 MG TABLET, manufactured by Neos Therapeutics Brands, LLC, is $17.9876 per EA (NDC 70165010030), effective Jun 24, 2026.

How has the price of COTEMPLA XR-ODT 8.6 MG TABLET changed over time?

Over the history we have for it, the NADAC for COTEMPLA XR-ODT 8.6 MG TABLET has risen 75.0%. It has been tracked across 432 weekly CMS publications since Mar 21, 2018.

What are the highest and lowest recorded NADAC prices for COTEMPLA XR-ODT 8.6 MG TABLET?

Since Mar 21, 2018, the NADAC for COTEMPLA XR-ODT 8.6 MG TABLET has ranged from a low of $10.2763 (Mar 21, 2018) to a high of $17.9876 (Jun 24, 2026), with a median of $14.2903 per EA.

Are there cheaper alternatives to COTEMPLA XR-ODT 8.6 MG TABLET?

No other NADAC-published product currently shares the active ingredient, strength, and dosage form of COTEMPLA XR-ODT 8.6 MG TABLET, so no direct lower-cost alternative is listed.

Who manufactures COTEMPLA XR-ODT 8.6 MG TABLET?

COTEMPLA XR-ODT 8.6 MG TABLET (NDC 70165010030) is labeled by Neos Therapeutics Brands, LLC, and CMS classifies it as a brand product.